Viridian Therapeutics, INC.\De (VRDN) — DEF 14A Filings
All DEF 14A filings from Viridian Therapeutics, INC.\De. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Viridian Therapeutics Files DEF 14A for FY2024
— Apr 25, 2025 Risk: low
Viridian Therapeutics, Inc. filed a DEF 14A on April 25, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation and other -
Viridian Therapeutics Announces 2024 Annual Meeting of Stockholders on June 17
— Apr 26, 2024 Risk: low
Viridian Therapeutics, Inc.\DE (VRDN) filed a Proxy Statement (DEF 14A) with the SEC on April 26, 2024. Annual Meeting scheduled for June 17, 2024, at 3:00 p.m.
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX